Paragonix Technologies, Inc.

Paragonix Technologies markets organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPak™ CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation. Paragonix is also developing transport devices for the lung and kidneys designed to improve donor organ quality and extending donor organ transport time.

The Paragonix® mission

Paragonix supports the transplant community by establishing the new standard of care for donor organ preservation. Our mission is to expand today’s boundaries in the transport of donor organs.